Even when injection of the adenovirus encoding MT-III gene started at the mean age of disease onset in ALS mice (~ 20 weeks), MT-III expression was found to prevent further loss of motor neurons and prolonged lifespan. The gene discussed is MT3; the disease is amyotrophic lateral sclerosis.